`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`MYLAN PHARMACEUTICALS INC.,
`
`Petitioner
`
`V.
`
`QUALICAPS CO., LTD,
`
`Patent Owner
`
`Case IPR2017-00203
`
`Patent 6,649,180
`
`PATENT OWNER’S UNOPPOSED MOTION FOR ADMISSION
`
`PRO HAC VICE OF MEGAN P. KEANE UNDER 37 C.F.R. § 42.10
`
`DC: (1428:3624
`
`
`
`lPR2017-00203
`
`1.
`
`Relief Requested
`
`Pursuant to 37 CPR. § 42.10, and in accordance with the Board’s Order,
`
`Paper No. 7 in Case IPR2013-00639, and the Notice of Filing Date Accorded to
`
`Petition (Paper No. 3), Patent Owner requests that the Board admit Megan P.
`
`Keane pro hac vice in this proceeding. Counsel for Petitioner has informed the
`
`undersigned that Petitioner does not oppose this motion.
`
`II.
`
`Statement of Facts
`
`37 C.F.R. §42.10(c) states that the Board “may recognize counsel pro hac
`
`vice during a proceeding upon a showing of good cause, subject to the condition
`
`that lead counsel be a registered practitioner and to any other conditions as the
`
`Board may impose. For example, where the lead counsel
`
`is
`
`a
`
`registered
`
`practitioner, a motion to appear pro liac vice by counsel who is not a registered
`
`practitioner may be granted upon showing that counsel is an experienced litigating
`
`attorney and has an established familiarity with the subject matter at issue in the
`
`proceeding.” The facts, supported by the attached Declaration of Megan P. Keane
`
`in Support of Patent Owner’s Motion for Admission Pro Hac Vice (“Keane
`
`Declaration”), establish good cause to admit Ms. Keane pro hac vice in this
`
`proceeding.
`
`1.
`
`Lead counsel, iessica L. Parezo, is a registered practitioner.
`
`
`
`IPR2017-00203
`
`2.
`
`Counsel, Megan P. Keane, is an experienced litigating attorney with
`
`over seven years in private law practice and has substantial experience with patent
`
`litigation. Keane Decl. at 'li 9. Ms. Keane has been counsel in over twenty patent
`
`infringement matters, inciuding cases pending in various district courts. Id. Ms.
`
`Keane is a member in good standing of the Pennsyivania State Bar and the District
`
`of Coiurnbia Bar. Id. at ‘ll 2. She is also admitted to practice in the United States
`
`Court of Appeals for the Federal Circuit and the United States District Court for
`
`the District of Columbia. Id. She has no suSpensions or disbarments from practice,
`
`nor any application for admission to practice denied, nor any sanctions or contempt
`
`citations. Id. at W 3—5.
`
`3.
`
`Ms. Keane was admitted to practice before this Board pro hac vice in
`
`IPR2016-00458. See Eli Lilly and Company v. The Trustees of The University of
`
`Pennsylvania, IPR2016-00458, Paper No. 42 (P.T.A.B. Nov. 21, 2016); Keane
`
`Decl. at ‘ll 8.
`
`4.
`
`Ms. Keane has familiarity with the subject matter and patent at issue
`
`in this proceeding, US. Patent No. 6,649,180 (“the ’i80 Patent”), including its
`
`prosecution history and the scientific field to which the ’180 Patent is addressed.
`
`Keane Deci. at il 10. Ms. Keane is advising the Patent Owner regarding the Patent
`
`Owner’s Response to the Petition.
`
`In addition, Ms. Keane is or has been counsel
`
`of record in patent
`
`infringement cases involving pharmaceutical
`
`formulation
`
`
`
`1PR2017-00203
`
`patents. These activities have required deveIOping a thorough understanding of the
`
`patent at issue in this proceeding, the prior art, and the relevant scientific field. 1d.
`
`5.
`
`Ms. Keane also has extensive experience litigating and advising
`
`clients relating to pharmaceutical patents. Specifically, she has experience working
`
`with experts and developing strategy in proceedings before the Patent Trial and
`
`Appeal Board relating to other pharmaceutical products. Id. at it 11.
`
`6.
`
`Ms. Keane has read and will comply with the Office Patent Triai
`
`Guide and the Board’s Rules for Practices for Trials set forth in Part 42 of the
`
`C.F.R., and she agrees to be subject to the USPTO Rules of Professional Conduct
`
`set forth in 37 ORR. §§ 11.101 et seq. and disciplinary jurisdiction under 37
`
`CPR. § 11.19(a).1d. at W 67.
`
`III. Analysis
`
`The facts contained in the Statement of Facts above, and contained in the
`
`Keane Declaration, establish that there is good cause to admit Ms. Keane pm [me
`
`vice in this proceeding, under 37 C.F.R. §42.10. Lead counsel
`
`is a registered
`
`practitioner, Ms. Keane is an experienced litigating attorney, and Ms. Keane has an
`
`established familiarity with the subject matter at issue in this proceeding.
`
`
`
`IPR2017-00203
`
`IV. Conclusion
`
`For the foregoing reasons, Patent Owner respectfuily requests that the Board
`
`admit Megan P. Keane pro hac vice in this proceeding.
`
`Respectfully submitted,fl
`
`
`
`arezo
`Registration No.: 50,286
`Andrea G. Reister
`
`
`
`Registration No.: 36,253
`Scott E. Kamholz
`
`Registration No.: 48,543
`COVINGTON & BURLI'NG LLiJ
`
`One CityCenter, 850 Tenth Street, NW
`Washington, DC 20001
`(202) 662-6000
`
`MaryAnne Armstrong
`Registration No: 40,069
`Lynde F. Herzbach
`Registration No.: 74,886
`BIRCH, STEWART, KOLASCH & BIRCH, LLP
`8110 Gatehouse Road, Suite 100 East
`
`Faiis Church, VA 22042
`(703) 205—8000
`
`Attorneys for Patent Owner
`
`Date: May 31, 2017
`
`
`
`CERTIFICATE OF SERVICE
`
`Pursuant to 37 C.F.R. § 42.6, I hereby certify that on this 3lst day of May
`
`2017, the "foregoing Patent Owner’s Unopposed Motion for Admission Pro Hac
`
`Vice of Megan P. Keane Under 37 CPR. § 42.10 was served by electronic mail,
`
`by agreement of the parties, on the following counsel of record for Petitioner.
`
`Mitchell G. Stockwell
`
`David C. Holloway
`Jonathan D. Olinger
`Miranda C. Rogers
`Mylan—WC—IPR@kilpatricktownsend.com
`Kilpatrick Townsend & Stockton LLP
`
`
`
`_
`_
`. Pa ezo, Esq.
`Jessica
`Reg. No.: 50,286
`
`
`
`
`
`Date: May 31, 2017
`
`